Your session is about to expire
← Back to Search
Other
e-cigarette for Electronic Cigarette Use
N/A
Waitlist Available
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up within 4 hours of e-cig use
Awards & highlights
Study Summary
This trial found that acute use of electronic cigarettes increased oxidative stress and inflammation.
Eligible Conditions
- Electronic Cigarette Use, Oxidative Stress, Inflammation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ within 4 hours of e-cig use
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 4 hours of e-cig use
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cellular Reactive Oxygen Species, units = % fluorescence
Secondary outcome measures
CD 14+ Monocyte, units = % of total cells
Trial Design
2Treatment groups
Experimental Treatment
Group I: shamExperimental Treatment1 Intervention
One time exposure to empty e-cig
Group II: E-cigExperimental Treatment1 Intervention
One time exposure to e-cig
Find a Location
Who is running the clinical trial?
University of California, Los AngelesLead Sponsor
1,538 Previous Clinical Trials
10,266,883 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,470 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have diabetes.You are in good health with no existing medical conditions.You have a lung disease.You have a heart condition.
Research Study Groups:
This trial has the following groups:- Group 1: E-cig
- Group 2: sham
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger